Abstract
Photodynamic therapy (PDT) of cancer obtains tumor selectivity in part from the preferential accumulation of photosensitizing drugs in tumor tissue. The optimization of PDT requires a knowledge of the time course of drug concentration and selectivity of drug for tumor. Most determinations of tissue levels of such PUT drugs have been made using chemical extraction of the drug from tissue biopsies.
© 1992 Optical Society of America
PDF ArticleMore Like This
Martin Austwick, Josephine Woodhams, Charles A Mosse, Caroline Elliot-Laize, Vadzim Chalau, Alexander J. MacRobert, Irving J. Bigio, and Stephen Bown
BTuC2 Biomedical Optics (BIOMED) 2008
Kin F Chan, Maiko Hermsmeier, Sinyoung Jeong, Sam Osseiran, Alexander Fast, Xin Chen, Akira Yamamoto, and Conor L. Evans
NM2C.2 Novel Techniques in Microscopy (NTM) 2019
D. Parmeswaran, P. Aruna, P.K. Gupta, and S. Ganesan
4433_128 European Conference on Biomedical Optics (ECBO) 2001